GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EV-to-EBIT

Bioqual (Bioqual) EV-to-EBIT : 0.00 (As of Jun. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Bioqual EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bioqual's Enterprise Value is $0.00 Mil. Bioqual's EBIT for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil. Therefore, Bioqual's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Bioqual's EV-to-EBIT or its related term are showing as below:

BIOQ's EV-to-EBIT is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 21.265
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bioqual's Enterprise Value for the quarter that ended in May. 2018 was $20.01 Mil. Bioqual's EBIT for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil. Bioqual's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2018 was 26.67%.


Bioqual EV-to-EBIT Historical Data

The historical data trend for Bioqual's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EV-to-EBIT Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.16 6.69 6.89 3.64 3.74

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.16 6.69 6.89 3.64 3.74

Competitive Comparison of Bioqual's EV-to-EBIT

For the Diagnostics & Research subindustry, Bioqual's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioqual's EV-to-EBIT falls into.



Bioqual EV-to-EBIT Calculation

Bioqual's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/5.336
=0.00

Bioqual's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioqual's EBIT for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual  (OTCPK:BIOQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bioqual's Earnings Yield (Joel Greenblatt) % for the quarter that ended in May. 2018 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: May. 2018 ) =EBIT / Enterprise Value (Q: May. 2018 )
=5.336/20.007349
=26.67 %

Bioqual's Enterprise Value for the quarter that ended in May. 2018 was $20.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioqual's EBIT for the trailing twelve months (TTM) ended in May. 2018 was $5.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bioqual's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines